Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma

Targeted and immune therapies have unquestionably improved the prognosis of melanoma patients. However the treatment of this neoplasm still requires approaches with a higher therapeutic index, in order to reduce shortcomings related to toxic effects and aspecific targeting. This means developing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chillà, Anastasia, Margheri, Francesca, Biagioni, Alessio, Del Rosso, Tommaso, Fibbi, Gabriella, Del Rosso, Mario, Laurenzana, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408438/
https://www.ncbi.nlm.nih.gov/pubmed/32630815
http://dx.doi.org/10.3390/cancers12071771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408438/
https://www.ncbi.nlm.nih.gov/pubmed/32630815
http://dx.doi.org/10.3390/cancers12071771

Ejemplares similares